J Transl Med, 2015 · DOI: 10.1186/s12967-015-0717-4 · Published: November 14, 2015
Mesenchymal stem cells (MSCs) are often expanded outside the body for clinical studies using pooled human platelet lysate (pHPL). This study addresses the issue of clot formation in pHPL-supplemented medium due to coagulation factors. The study introduces a method to deplete fibrinogen from pHPL by clotting the pHPL in the medium, mechanically disrupting the hydrogel, and removing the resulting fibrin pellet. This process allows for heparin-free MSC propagation. The method facilitates a standardized and GMP-grade generation of medium for future clinical studies by providing entirely humanized cell culture media with high medium recovery rates and low remaining fibrinogen amounts.
The method offers a safer, fully humanized alternative to FBS and porcine heparin in MSC culture for clinical trials.
The protocol allows for a standardized and GMP-compliant production of MSC culture media.
The interplay between fibrinogen, heparin, and MSCs needs further investigation to understand the molecular mechanisms and effects on MSC functionality in vivo.